The company has entered into a Business Transfer Agreement (BTA), a Share Subscription Agreement (SSA) and a Shareholders’ Agreement (SHA) with Strand Life Sciences in relation to the proposed Business Combination. The BTA provides for the transfer by the company to Strand Life Sciences of the Triesta Sciences business unit, and the SSA provides for the issue of shares of Strand Life Sciences to the company in consideration thereof, resulting in the company acquiring 48.5% shareholding in Strand Life Sciences on a fully-diluted basis post the Business Combination.
HealthCare Global Enterprises (HCG) is the largest provider of cancer care in India. Through its network of 15 comprehensive cancer centres spread across India, HCG has brought advanced cancer care to the doorstep of millions of people.
Bhupendra Singh Chundawat is a seasoned technology journalist with over 22 years of experience in the media industry. He specializes in covering the global technology landscape, with a deep focus on manufacturing trends and the geopolitical impact on tech companies. Currently serving as the Editor at Udaipur Kiran, his insights are shaped by decades of hands-on reporting and editorial leadership in the fast-evolving world of technology.